无细胞DNA水平与COPD恶化和死亡率有关
Sarah A Ware1, Corrine R Kliment2, Luca Giordano1
1Department of Medicine, Division of Cardiology, Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh School of Medicine, 200 Lothrop Street BST W1044, Pittsburgh, PA, 15261, USA.
Respiratory research
|January 18, 2024
概括
无等离子细胞的线粒体和核DNA (cf-mtDNA和cf-nDNA) 可以预测慢性阻塞性肺病 (COPD) 的进展. 升高的cf-nDNA与COPD患者的死亡风险增加有关.
科学领域:
- 生物标志物 生物标志物
- 基因组学就是基因组学.
- 肺部医学 肺部医学
背景情况:
- 慢性阻塞性肺病 (COPD) 缺乏可靠的指标来预测疾病进展和表型.
- 香烟烟雾会破坏核和线粒体DNA,释放无细胞DNA (cf-DNA) 进入循环.
- 血cf-DNA可能反映COPD的疾病生理学和临床结果.
研究的目的:
- 研究血细胞自由线粒体DNA (cf-mtDNA) 和细胞自由核DNA (cf-nDNA) 水平与COPD严重程度,恶化和死亡率之间的关联.
- 评估cf-mtDNA和cf-nDNA作为COPD预测生物标志物的潜力.
主要方法:
- 在ECLIPSE研究中的2,702名参与者的血中量化mtDNA和nDNA拷贝数.
- 分析cf-mtDNA和cf-nDNA水平和临床参数之间的关联,包括疾病严重程度,恶化和死亡率.
主要成果:
- 血cf-mtDNA水平与轻度/中度和重度COPD患者的未来恶化率以及具有高乙氨基细胞计数的患者具有积极的相关性.
- 血cf-nDNA水平与死亡风险增加正相关 (HR 1.33).
- 低cf-mtDNA和高cf-nDNA的组合进一步增加了死亡风险 (HR 1.62).
结论:
- 血cf-mtDNA和cf-nDNA显示出作为评估COPD严重程度和进展的定量生物标志物的潜力.
- 将cf-mtDNA和cf-nDNA整合到临床评估中可能会改善COPD患者的治疗和预测结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
275
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
275
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


